iRhythm Technologies Announces Results of GUARD-AF Trial
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024 Leveraging iRhythm’s Zio®patch-based long-term continuous monitoring (LTCM), GUARD-AF […]
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024 Leveraging iRhythm’s Zio®patch-based long-term continuous monitoring (LTCM), GUARD-AF […]
Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest […]
NIO delivered 20,176 vehicles in August 2024 NIO delivered 128,100 vehicles year-to-date in 2024, increasing by 35.8% year-over-year Cumulative deliveries […]
GUANGZHOU, China, Sept. 01, 2024 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a […]
Data from Integrated Safety Analysis Across Three Clinical TrialsReinforces Robust Safety Profile of Aficamten Analysis from FOREST-HCM Demonstrates SuccessfulWithdrawal of […]
Additional Data from SEQUOIA-HCM Demonstrate Favorable Cardiac Remodelingby Cardiac MRI, Improvements in Cardiac Structure and Function by Echocardiography,Symptom Relief and […]